Dr. Randa Tao
Claim this profileHuntsman Cancer Institute/University of Utah
Area of expertise
Esophageal Cancer
Randa Tao has run 3 trials for Esophageal Cancer. Some of their research focus areas include:
Esophageal Adenocarcinoma
Randa Tao has run 2 trials for Esophageal Adenocarcinoma. Some of their research focus areas include:
Affiliated Hospitals
Huntsman Cancer Institute/University Of Utah
University Of Utah Sugarhouse Health Center
Clinical Trials Randa Tao is currently running
Hypoxia-Guided Radiation
for Esophageal Cancer
This is a Phase I trial evaluating the safety of personalized radiation therapy based on levels of hypoxia identified on FMISO-PET and MRI. All patients will receive a baseline FMISO positron emission tomography (PET) and MRI to identify levels of hypoxia. Patients with tumor hypoxia will receive a higher dose of radiation therapy. Subjects who do not have hypoxic tumors will be treated with the standard-of-care radiation regimen. After fraction 10 of radiation therapy, an additional MRI will be performed. If this interim MRI demonstrates little or no response (as defined in Section 6), an optional boost radiation dose can be administered. Trial enrollment will be conducted in two parts. In Part 1, eight patients will be enrolled. After all eight patients have completed the 30 day dose-limiting toxicity (DLT) period, enrollment will be placed on hold and safety will be evaluated. During the interim analysis, one additional patient will be allowed to be enrolled in the trial. If the trial meets stopping rules as described in Section 11.3, the trial will be re-evaluated by the Data and Safety Monitoring Committee (DSMC) and the Principal Investigator. However, if the rate of DLTs remains below the unacceptable toxicity rate, enrollment will open to the enrollment of eight more patients.
Recruiting
1 award
Phase 1
7 criteria
Ablative Therapy + Systemic Therapy
for Colorectal Cancer
This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients who are not participating in a study is treatment with intravenous (IV) (through a vein) and/or oral medications (systemic therapy) to help stop the cancer sites from getting larger and the spread of the cancer to additional body sites. Ablative means that the intention of the local treatment is to eliminate the cancer at that metastatic site. The ablative local therapy will consist of very focused, intensive radiotherapy called stereotactic ablative radiotherapy (SABR) with or without surgical resection and/or microwave ablation, which is a procedure where a needle is temporarily inserted in the tumor and heat is used to destroy the cancer cells. SABR, surgical resection, and microwave ablation have been tested for safety, but it is not scientifically proven that the addition of these treatments are beneficial for your stage of cancer. The addition of ablative local therapy to all known metastatic sites to the usual approach of systemic therapy could shrink or remove the tumor(s) or prevent the tumor(s) from returning.
Recruiting
2 awards
Phase 3
More about Randa Tao
Clinical Trial Related
5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Randa Tao has experience with
- Radiation Therapy
- FMISO PET CT
- Capecitabine
- Fluorouracil
- Leucovorin
- Oxaliplatin
Breakdown of trials Randa Tao has run
Esophageal Cancer
Esophageal Adenocarcinoma
Esophageal cancer
Stomach Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Randa Tao specialize in?
Randa Tao focuses on Esophageal Cancer and Esophageal Adenocarcinoma. In particular, much of their work with Esophageal Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Randa Tao currently recruiting for clinical trials?
Yes, Randa Tao is currently recruiting for 2 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Randa Tao has studied deeply?
Yes, Randa Tao has studied treatments such as Radiation Therapy, FMISO PET CT, Capecitabine.
What is the best way to schedule an appointment with Randa Tao?
Apply for one of the trials that Randa Tao is conducting.
What is the office address of Randa Tao?
The office of Randa Tao is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.